Free Trial

Baxter International (BAX) Competitors

Baxter International logo
$30.60 -0.76 (-2.42%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$31.12 +0.52 (+1.72%)
As of 06/13/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAX vs. BDX, EW, IDXX, RMD, DXCM, STE, PODD, HOLX, MASI, and GMED

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Masimo (MASI), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.

Baxter International vs. Its Competitors

Baxter International (NYSE:BAX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.

Becton, Dickinson and Company has a net margin of 8.47% compared to Baxter International's net margin of -5.05%. Baxter International's return on equity of 16.67% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International-5.05% 16.67% 4.93%
Becton, Dickinson and Company 8.47%15.74%7.29%

Baxter International currently has a consensus target price of $37.25, suggesting a potential upside of 21.73%. Becton, Dickinson and Company has a consensus target price of $219.22, suggesting a potential upside of 27.41%. Given Becton, Dickinson and Company's higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
1 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.44
Becton, Dickinson and Company
0 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.36

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Baxter International has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$10.77B1.46-$649M-$1.10-27.82
Becton, Dickinson and Company$20.87B2.36$1.71B$5.2432.84

Baxter International received 130 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 65.51% of users gave Baxter International an outperform vote while only 62.07% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Baxter InternationalOutperform Votes
737
65.51%
Underperform Votes
388
34.49%
Becton, Dickinson and CompanyOutperform Votes
607
62.07%
Underperform Votes
371
37.93%

In the previous week, Becton, Dickinson and Company had 11 more articles in the media than Baxter International. MarketBeat recorded 22 mentions for Becton, Dickinson and Company and 11 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.34 beat Baxter International's score of 0.92 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
17 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Baxter International pays an annual dividend of $0.68 per share and has a dividend yield of 2.2%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.4%. Baxter International pays out -61.8% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 79.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Becton, Dickinson and Company beats Baxter International on 13 of the 21 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$15.70B$4.32B$5.57B$19.68B
Dividend Yield2.25%42.67%5.27%3.80%
P/E Ratio-23.9128.6426.7534.98
Price / Sales1.4668.00403.9842.66
Price / Cash6.4551.0838.2517.51
Price / Book1.835.746.964.78
Net Income-$649M$66.95M$3.23B$1.02B
7 Day Performance1.09%-3.05%-1.22%0.82%
1 Month Performance-1.39%0.71%6.34%1.32%
1 Year Performance-9.41%18.95%33.05%10.65%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAX
Baxter International
4.3986 of 5 stars
$30.60
-2.4%
$37.25
+21.7%
-9.4%$15.70B$10.77B-23.9160,000News Coverage
Analyst Downgrade
Options Volume
BDX
Becton, Dickinson and Company
4.9534 of 5 stars
$172.47
+0.0%
$219.22
+27.1%
-26.4%$49.43B$20.87B28.6577,000Positive News
Options Volume
EW
Edwards Lifesciences
4.5635 of 5 stars
$76.35
-1.5%
$80.20
+5.0%
-13.9%$44.79B$5.52B10.9517,300Positive News
IDXX
IDEXX Laboratories
3.784 of 5 stars
$518.60
-1.2%
$536.00
+3.4%
+3.7%$41.71B$3.93B48.6010,800News Coverage
Positive News
Analyst Forecast
RMD
ResMed
4.0342 of 5 stars
$251.02
-0.5%
$259.33
+3.3%
+17.7%$36.81B$5.02B29.648,160Positive News
Insider Trade
DXCM
DexCom
4.7447 of 5 stars
$85.68
-1.1%
$98.32
+14.7%
-29.3%$33.60B$4.15B59.927,600Positive News
STE
STERIS
4.5606 of 5 stars
$242.67
-0.4%
$263.83
+8.7%
+10.5%$23.87B$5.46B51.5216,000Ex-Dividend
Analyst Upgrade
Analyst Revision
PODD
Insulet
4.2029 of 5 stars
$305.66
-2.0%
$318.41
+4.2%
+52.0%$21.51B$2.20B52.792,600Analyst Downgrade
HOLX
Hologic
4.8887 of 5 stars
$64.57
+0.4%
$77.42
+19.9%
-9.8%$14.39B$4.03B20.376,940Positive News
Short Interest ↓
MASI
Masimo
4.0877 of 5 stars
$171.88
-0.1%
$191.60
+11.5%
+18.8%$9.32B$2.13B118.546,200
GMED
Globus Medical
4.7534 of 5 stars
$60.35
+0.7%
$94.00
+55.8%
-10.3%$8.17B$2.51B80.462,600Analyst Forecast

Related Companies and Tools


This page (NYSE:BAX) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners